Heart watch: new study tests At-Home monitoring to protect new moms

NCT ID NCT05534932

Ongoing Prevention Sponsor: University of Chicago Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether remote monitoring and guideline-directed therapy can prevent heart dysfunction in African American women who had preeclampsia. Twenty participants will use a tablet, blood pressure cuff, and scale at home for three months after delivery. The goal is to see if this approach improves heart strain measurements compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Remote patient monitoring (blood pressure cuff, scale, tablet)
What this could lead to: If it works, this could point toward a simple way to prevent lasting heart damage after preeclampsia in a high-risk group.
What could go wrong: This is a very small pilot study with only 20 participants, so results may not apply broadly. The intervention is monitoring, not a new drug, so the impact may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREECLAMPSIA POSTPARTUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder hypertensive disorder preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREECLAMPSIA POSTPARTUM

Contacts and locations

Locations

University of Chicago Hospital

Chicago, Illinois, 60637, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.